老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

眾巢醫學

0.2136
+0.00934.55%
成交量：69.70萬
成交額：15.77萬
市值：656.90萬
市盈率：-1.12
高：0.2570
開：0.1843
低：0.1843
收：0.2043
52周最高：1.59
52周最低：0.1843
股本：3,075.39萬
流通股本：1,865.60萬
量比：4.20
換手率：3.74%
股息：- -
股息率：- -
每股收益(TTM):-0.1900
每股收益(LYR):-0.1236
淨資產收益率：-5.93%
總資產收益率：-2.90%
市淨率：0.32
市盈率(LYR):-1.73

資料載入中...

總覽公司新聞資訊公告
2026/01/15

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/08/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/07/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/21

SEC問詢函

Form CORRESP - Correspondence
2025/06/07

SEC問詢函

Form CORRESP - Correspondence
2025/05/20

SEC問詢函

Form CORRESP - Correspondence
2025/05/07

SEC問詢函

Form CORRESP - Correspondence
2025/04/25

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/27

SEC問詢函

Form CORRESP - Correspondence
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/12

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/09

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/08

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/02

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

超過5%披露

General statement of acquisition of beneficial ownership
2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多